Category Archive for ‘BioTech’

Bears Bite Back, Arena Pharmaceuticals (ARNA) Moving Higher

12:35pm (EST) We talked about the two levels of resistance the bulls faced coming into the week and yesterday’s test to the first level was a given.  We have said the test to upper resistance would be harder to clear due to the lack of catalysts and this morning weRead more

More

Bears Show Teeth, Bulls Bite Back

12:55pm Wall Street notes… We were like a kid on Christmas as futures were showing a triple-digit loss for the blue-chips when we hit the rack.  We knew when we woke up one of our presents would be a biotech trade that could triple at the open.  We got aRead more

More

Bulls Pushing, Bears Pulling

12:40pm (EST) The market is slightly positive heading into the second half of trading as jobless claims remained flat which was “good news” as many were expecting worse numbers.  News from overseas has been “positive” following the takeover of Spain’s third largest bank by its government which has helped itsRead more

More

Bulls Walking on Thin Ice

Wall Street, Seattle Genetics (SGEN) Pop, Then Drop

12:55pm (EST) The market is getting a lift today as the bulls push resistance following a 4-week losing streak but the major indexes are off their highs.  There hasn’t been any major headline news, negative that is, and economic gibberish doesn’t hit the tape until Tuesday which has given theRead more

More

Seattle Genetics (SGEN) Update

1:15pm (EST) We wanted to give a quick update on Seattle Genetics (SGEN, $20.33, HALTED) as we have just learned the FDA committee has voted 10-0 in favor of one of its two drugs with another meeting scheduled this afternoon to review the other.  So far, so good…   ]]>

More

Seattle Genetics (SGEN) Halted; Google (GOOG) Earnings Due

12:25pm (EST) The bulls are trying to even things up for the week but are having trouble holding the gains off the open and still have a ways to go to get back to even.  JPMorgan (JPM, $40.77, up $1.15) provided some enthusiasm this morning after beating Wall Street’s expectationsRead more

More

Second Half of 2011: Volatility

9:00am (EST) The bulls made it 4 in-a-row on Thursday by ending June with a bang and their drive for five is looking pretty good as futures are up this morning.  Yesterday’s gains were a combination of positive Greece news, window dressing, and a continued bounce off the 200-day moving averages.  ThrowRead more

More

Remembering a Good One

12:20pm (EST) “Live from the New York Stock Exchange…”    It’s rare we divert your attention away from the market but today we wanted to take the time to remember one of the truly best talking heads out there.  Mark Haines, CNBC anchorman, has passed away at age 65. We grewRead more

More

Vivus (VVUS) Rising on New Drug Prospect

1:00pm (EST) Vivus (VVUS, $8.40, up $0.32) is back in the spotlight but this time it’s not for news concerning its diet drug, Qnexa.  We have mentioned the battle between Vivus and others to be the first company to get a diet pill approved but Vivus also has plans toRead more

More

CFTC Disclosure:

GOVERNMENT REGULATIONS REQUIRE DISCLOSURE OF THE FACT THAT WHILE THESE METHODS MAY HAVE WORKED IN THE PAST, PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE PERFORMANCE. WHILE THERE IS A POTENTIAL FOR PROFITS THERE IS ALSO A RISK OF LOSS. A LOSS INCURRED IN CONNECTION WITH Momentum Options Trading, LLC CAN BE SIGNIFICANT. YOU SHOULD THEREFORE CAREFULLY CONSIDER WHETHER TRADING IS SUITABLE FOR YOU IN LIGHT OF YOUR FINANCIAL CIRCUMSTANCE. THERE IS SUBSTANTIAL RISK IN TRADING. A LOSS INCURRED IN CONNECTION WITH FUTURES TRADING CAN BE SIGNIFICANT. WE MAKE NO CLAIM REGARDING PAST OR FUTURE PERFORMANCE. WE MERELY TRACK EVERY TRADE AND SHOW THE PERFORMANCE OF ALL TRADES THE SYSTEM OR NEWSLETTER PRODUCES. SIMULATED TRADING IS DIFFERENT THAN TRADING REAL MONEY. HYPOTHETICAL RESULTS ARE NOT REAL RESULTS. PLEASE CONTACT YOUR BROKER ABOUT THE RISK OR TRADING STOCKS, OPTIONS OR FUTURES. ALL COMMUNICATIONS ARE OPINIONS NOT ADVICE.

CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.